CDK1 and cancer: PKMYT1 negatively regulates CDK1, and its inhibition results in premature mitotic entry and cell death, particularly in CCNE1-amplified cells.36,53 Pharmacological inhibitors of PKMYT1, such as RP6306, have been developed and validated in cancers with CCNE1 amplification.